In-line coagulation assessment for ultrafiltration fouling reduction to treat secondary effluent for water reuse

Low pressure membranes are attracting attention for their potential to improve secondary effluent quality, but membrane fouling can limit their widespread applicability. In this study, in-line coagulation as pre-treatment to ultrafiltration (UF) was investigated using a bench-scale hollow fiber membrane at a constant flux of 33 L/m(2) h. Membrane fouling was monitored by observing change in trans-membrane pressure when the membrane was fed with secondary effluent and in-line coagulated secondary effluent over a 24-h period. The impact of four coagulants at different dosages on reversible and irreversible membrane fouling and permeate quality was studied. It was found that in-line coagulation improved UF performance to varying degrees depending on coagulant type and dosage. Generally, higher reduction of fouling was achieved by increasing coagulant dosage within the 0.5-5.0 mg/L range investigated. Ferric-based coagulants were better than aluminum-based coagulants with respect to improving membrane performance for the secondary effluent investigated, even at low dosages (0.5 mg/L). Further investigations are required to determine how in-line coagulation affects removal of organic compounds through UF membranes.

Automated summary

In-line coagulation as pre-treatment to ultrafiltration (UF) improves UF performance and reduces membrane fouling. Different types and dosages of coagulants have varying effects on UF performance, with generally higher reduction of fouling achieved by increasing coagulant dosage. Ferric-based coagulants are better than aluminum-based coagulants for improving membrane performance.